NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bath & Body securities between June 4, 2024 and November 19, 2025, bo ...

LOS ANGELES--(BUSINESS WIRE)--Bath & Body Works, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBWI. ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - Investors have until March 13, 2026, to request to be appointed to lead the case, which is based on claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2][3]. - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through these new categories [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy had not grown the customer base, the stock fell by $5.22, or 24.8%, from $21.04 to $15.82 per share [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 13, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements that negatively impacted investors [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against the Company - The complaint alleges that Bath & Body Works made false and misleading statements regarding its business strategy, which included seeking "adjacencies, collaborations and promotions" that failed to grow its customer base and net sales [4]. - The company reportedly relied on brand collaborations to "carry quarters" despite experiencing weak financial results, leading to misleading public statements throughout the class period [4]. - Investors suffered damages when the truth about the company's performance was revealed [4].

Group 1 - A shareholder class action lawsuit has been filed against Bath & Body Works, alleging false and misleading statements regarding the company's growth strategy and financial performance [1] - The lawsuit claims that Bath & Body Works's strategy did not effectively grow the customer base or deliver the expected growth in net sales [1] - It is alleged that the company relied on brand collaborations to mask weak underlying financial results, leading to doubts about meeting previously issued financial guidance [1] Group 2 - Investors who purchased Bath & Body Works shares between June 4, 2024, and November 19, 2025, and suffered significant losses are encouraged to seek legal advice [2] - Holzer & Holzer, LLC is a law firm specializing in shareholder class action and derivative litigation, with a history of recovering substantial amounts for shareholders affected by corporate misconduct [3]

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Bath & Body Works, Inc. for alleged misrepresentations regarding the Company's financial guidance during the period from June 4, 2024, to November 19, 2025 [1][2]. Group 1 - The lawsuit represents a class of investors who purchased or acquired Bath & Body Works securities within the specified timeframe [1]. - Defendants are accused of making misrepresentations concerning the Company's financial guidance [2]. - Interested parties can file to serve as lead plaintiff by March 13, 2026, with no fees or expenses required from shareholders [3]. Group 2 - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented both individual investors and large pension funds [4].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who purchased Bath & Body Works, Inc. (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, alleging that the company misled investors regarding its business strategy [1]. Allegations - The complaint states that Bath & Body Works failed to disclose that its strategy of pursuing "adjacencies, collaborations, and promotions" was not effectively growing its customer base or achieving the projected growth in net sales [2]. - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results and was unlikely to meet its previously issued financial guidance [2]. Financial Performance - On November 20, 2025, Bath & Body Works reported disappointing third-quarter results, with revenue declining by 1% year-over-year, missing the guidance of 1-3% growth, and a net income drop of 26% to $77 million [3]. - The company revised its full-year guidance for net sales and reduced expected earnings per diluted share from $3.28 to "at least $2.83" [3]. - In an investor presentation, Bath & Body Works acknowledged that its previous strategy had not expanded its total customer base and identified issues such as reduced focus on core categories and over-reliance on promotions [3]. Market Reaction - Following the announcement of disappointing results and the new business strategy, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [4].

Core Insights - Bath & Body Works is launching new rose-focused fragrances, including the innovative Nocturnal Rose, to meet the growing consumer demand for modern and luxurious scents featuring rose [2][3][8] Product Launch - The new Nocturnal Rose is a genderless fragrance with notes of black pepper, wild rose, and cedarwood, developed in collaboration with Givaudan fragrance house [3][4] - The brand is also reintroducing popular fragrances such as Covered in Roses, Rose, "Inspire Love" Rose & Vanilla, and Heirloom Rose, catering to diverse consumer preferences [8][9] Fragrance Characteristics - Nocturnal Rose is described as a contemporary reimagining of the classic rose, inspired by the rare Rose de Mai, and embodies modern luxury with a unique intensity [4][5] - The rose fragrances are available in various forms, including fine fragrance mists, eau de parfum, candles, and body care products, all dermatologist-approved and formulated without parabens and sulfates [6][10] Market Positioning - Bath & Body Works aims to appeal to consumers looking for both self-purchase and gift options, especially with Valentine's Day approaching, by offering a range of rose-themed products [7][8] - The packaging of the new fragrances reflects current fashion trends, featuring a moody color palette that enhances the overall aesthetic appeal [5][8] Company Overview - Bath & Body Works is a leading brand in personal care and home fragrance, with a strong presence in the U.S. and international markets, operating 1,934 company-operated locations and 544 franchised locations as of November 1, 2025 [11]

Group 1 - Deutsche Bank has resumed coverage of key stocks in the global brand, discount retail, and professional beauty sectors, expressing optimism as it enters 2026, anticipating a "risk-on" macro environment despite potential fluctuations [1] - Analyst Christina Katay noted that the revenue trend in the first half of the year will remain robust due to favorable weather conditions and increased tax refunds, which are seen as drivers for same-store sales growth [1] - The bank estimates that the "Great Beauty Act" will increase tax refunds by approximately $55 billion, with total tax refunds in 2024 projected at $461 billion [1] Group 2 - The expected tax refunds will primarily benefit low- to middle-income consumers facing cost-of-living challenges, while affluent households are anticipated to benefit from increased state and local tax (SALT) deductions [2] - Deutsche Bank has assigned a "Buy" rating to stocks including Amphenol (AS.US), Birkenstock (BIRK.US), Ulta Beauty (ULTA.US), Ralph Lauren (RL.US), Ross Stores (ROST.US), and TJX Companies (TJX.US) [2] - The bank holds a more conservative view on stocks such as Bath & Body Works (BBWI.US), Burlington Stores (BURL.US), Nike (NKE.US), and Lululemon (LULU.US), assigning them a "Hold" rating [2]